Takahiro Haeno

Dr. Takahiro Haeno

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
AHAki Hanamoto
Aki Hanamoto
HTHirokazu Tanaka
Hirokazu Tanaka
KFKo Fujimoto
Ko Fujimoto
THTakahiro Haeno
Takahiro Haeno
YMYoshiaki Miyake
Yoshiaki Miyake
IMItaru Matsumura
Itaru Matsumura
Background: FLT3 mutations, including internal tandem duplication (ITD) and tyrosine kinase domain (TKD) point mutations, represent common genetic alterations in acute myeloid leukemia (AML), with FLT3-ITD associated with poor prognosis. Although FLT3 tyrosine kinase inhibitors (TKIs), such as quizartinib (Quiz) and gilteritinib, have improved clinical outcomes, secondary TKD mutations, particularly the gatekeeper mutation F691L, confer significant resistance. We previously demonstrated that chlorpromazine (CPZ), an antipsychotic drug, inhibits clathrin-mediated endocytosis and selectively suppresses the growth of cancer cells harboring mutant receptor tyrosine kinases. Methods: In this study, we examined the efficacy of CPZ in overcoming TKI resistance using Ba/F3 cells expressing FLT3-ITD or FLT3-ITD/F692L, the murine analog of F691L. Results: Quiz inhibited proliferation of FLT3-ITD cells but was ineffective against FLT3-ITD/F692L cells. CPZ suppressed growth in both cell types. Co-treatment with CPZ and Quiz exhibited synergistic effects in FLT3-ITD cells, but not in FLT3-ITD/F692L cells. CPZ reduced STAT5 phosphorylation and modulated downstream signaling in FLT3-ITD cells, while only partially affecting STAT5 in FLT3-ITD/F692L cells. Expression of constitutively active STAT5 partially rescued CPZ-induced growth inhibition. Conclusions: These findings suggest that STAT5 suppression is a key mechanism of CPZ’s antileukemic activity and support its potential as a therapeutic strategy for FLT3-ITD-positive AML.

2 February 2026 in Cancer Medicine
Verified
Journal Article
Open access
THTakahiro Haeno
Takahiro Haeno
KSKazuko Sakai
Kazuko Sakai
SMShuji Minamoto
Shuji Minamoto
DNDaiki Nakatsu
Daiki Nakatsu
MVMarco A. De Velasco
Marco A. De Velasco
KNKazuto Nishio
Kazuto Nishio
Background: Intratumor heterogeneity (ITH), characterized by the coexistence of genetically distinct subclones within a tumor, has been associated with adverse clinical outcomes in various cancers. However, the clinical and biological implications of ITH in diffuse large B‐cell lymphoma (DLBCL) are still incompletely understood. Materials & Methods: In this study, we applied a SNP‐array–based approach to assess the clonal complexity in formalin‐fixed, paraffin‐embedded tumor specimens obtained from newly diagnosed patients with advanced‐stage DLBCL ( n = 74) by calculating the clonal composition (CC) number. Rseults: Patients with Poly‐CC tumors (CC ≥ 1), which accounted for 79.7% of the cases, had a 5‐year event‐free survival rate of 38.9%, compared with 69.1% in those with Mono‐CC tumors (CC = 0) (Log‐rank p = 0.0520). This association reached statistical significance in the activated B‐cell (ABC) subtype ( n = 35, Log‐rank p = 0.0450) but not in the germinal center B‐cell (GCB) subtype ( n = 30, Log‐rank p = 0.910). Gene set enrichment analysis revealed upregulation of cell cycle–related pathways in Poly‐CC tumors, consistent with the significantly higher Ki‐67 positivity rate than in Mono‐CC tumors, as confirmed by immunohistochemistry ( p = 0.00227). Within the ABC subtype, Poly‐CC (Poly‐ABC) tumors exhibited more differentiated transcriptional states and enrichment of IRF4‐associated gene signatures as compared with Mono‐CC (Mono‐ABC) tumors. Conversely, IFN‐γ and IFN‐α response pathways and the IL‐6/JAK‐STAT3 signaling pathway were markedly suppressed in the Poly‐ABC tumors. Furthermore, Poly‐ABC tumors carried a significantly higher number of pathogenic mutations as compared with Mono‐ABC tumors ( p = 0.0147). Conclusion: These results suggest that clonal complexity captures tumor‐intrinsic features and biological diversity in DLBCL, especially in the ABC subtype, offering novel insights into the disease pathogenesis.